Systemic 7,8-Dihydroxyflavone Treatment Protects Immature Retinas Against Hypoxic-Ischemic Injury via Müller Glia Regeneration and MAPK/ERK Activation

Investigative Ophthalmology & Visual Science
Hsiu-Mei HuangYing-Chao Chang

Abstract

Perinatal hypoxic-ischemic (HI) injury causes significant damages in the immature retina. The brain-derived neurotrophic factor is well known for its neuroprotective role but has limited clinical applications. A selective agonist of tyrosine kinase receptor B, 7,8-dihydroxyflavone (DHF), is a powerful therapeutic tool, when administered systemically. However, it remains unclear whether DHF treatment can protect the immature retinas against HI injury. Postnatal (P) day 7 rat pups were intraperitoneally injected with DHF or vehicle 2 hours before and 18 hours after being subjected to HI injury. The outcomes were assessed at various timepoints after injury by electroretinography and histologic examinations. Neurogenesis was assessed by double-labeling of retinal sections with 5-bromo-2'-deoxyuridine and different neuronal markers. At P8, 24-hours postinjury, brain-derived neurotrophic factor mRNA levels in the retina decreased significantly. DHF treatment partially protected immature retinas at both histologic and functional levels between P14 and P30 but did not prevent apoptosis, inflammation, or damage of the blood-retinal barrier (BRB) at P8. On the other hand, DHF treatment promoted the survival of proliferating inner retinal...Continue Reading

References

Dec 1, 1989·Early Human Development·J van Hof-Van DuinW P Fetter
Apr 1, 1995·Developmental Medicine and Child Neurology·B LunaR D Guthrie
Oct 1, 1994·Developmental Medicine and Child Neurology·M G PikeL M Dubowitz
Jun 1, 1997·Developmental Medicine and Child Neurology·A OkumuraK Watanabe
Jan 22, 1998·Pediatric Neurology·G CioniJ van Hof-van Duin
Aug 26, 1998·Neuropediatrics·G LanziP E Bianchi
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·G OchsK V Toyka
Apr 5, 2003·Annual Review of Biochemistry·Eric J Huang, Louis F Reichardt
Jul 23, 2003·Developmental Biology·Andy J Fischer, Thomas A Reh
Apr 20, 2004·Progress in Retinal and Eye Research·Peter HitchcockDeborah Otteson
Sep 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Sotaro OotoMasayo Takahashi
Jul 15, 2006·Progress in Retinal and Eye Research·Andreas BringmannAndreas Reichenbach
Jan 9, 2008·The Journal of Pharmacology and Experimental Therapeutics·Tiziana GenoveseSalvatore Cuzzocrea
Nov 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Mike O KarlThomas A Reh
May 26, 2009·Progress in Retinal and Eye Research·Ashutosh P JadhavConstance L Cepko
Aug 8, 2009·Progress in Retinal and Eye Research·Andreas BringmannAndreas Reichenbach
Aug 28, 2009·Investigative Ophthalmology & Visual Science·Arthur J WeberChristine D Harman
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sung-Wuk JangKeqiang Ye
Mar 23, 2010·Trends in Molecular Medicine·M O Karl, T A Reh
Jul 14, 2010·Expert Review of Obstetrics & Gynecology·C Michael Cotten, Seetha Shankaran
Feb 10, 2011·Nature Communications·Chikako HaradaTakayuki Harada
Jun 7, 2012·Pediatric Research·Hsiu-Mei HuangYing-Chao Chang
Oct 12, 2012·Journal of Molecular Neuroscience : MN·Vivek K GuptaStuart L Graham
Jan 12, 2013·Investigative Ophthalmology & Visual Science·Caridad Galindo-RomeroMarta Agudo-Barriuso
May 30, 2013·Stroke; a Journal of Cerebral Circulation·Pi-Lien HungYing-Chao Chang
Jul 16, 2015·Investigative Ophthalmology & Visual Science·Hsiu-Mei HuangYing-Chao Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.